Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alcoholism and Schizophrenia: Effects of Clozapine

NCT00169026 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

NCT NCT00169026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00169026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alcoholism and Schizophrenia: Effects of Clozapine
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
May 31, 1999
Completion date
January 31, 2004
Enrollment
64
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol abuse, dual diagnosis, psychotic disorder, schizoaffective disorder, schizophrenia, substance abuse